Antisense antibacterial compounds and methods
US10391098B2 · kind B2 · utility
1Cited by
20References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 15, 2015 |
| Grant date | Aug 27, 2019 |
| Priority date | — |
| Expiry date | May 15, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are antisense oligomers targeted against or genes associated with a biochemical pathway and/or cellular process, and related compositions and methods of using the oligomers and compositions to treat an infected mammalian subject, for example, as primary antimicrobials or as adjunctive therapies with classic antimicrobials.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.